TMCI Stock Summary and Trading Ideas (Treace Medical Concepts | NASDAQ:TMCI)

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Treace Medical Concepts trades on the NASDAQ stock market under the symbol TMCI.

As of December 22, 2025, TMCI stock price declined to $2.48 with 1,316,704 million shares trading.

TMCI has a beta of 1.44, meaning it tends to be more sensitive to market movements. TMCI has a correlation of 0.12 to the broad based SPY ETF.

TMCI has a market cap of $158.02 million. This is considered a Micro Cap stock.

Last quarter Treace Medical Concepts reported $50 million in Revenue and -$.26 earnings per share. This beat revenue expectation by $619,848 and exceeded earnings estimates by $.01.

In the last 3 years, TMCI traded as high as $27.97 and as low as $2.43.

The top ETF exchange traded funds that TMCI belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

TMCI has underperformed the market in the last year with a price return of -64.4% while the SPY ETF gained +17.1%. TMCI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -64.1% and -5.0%, respectively, while the SPY returned +3.0% and +0.5%, respectively.

TMCI support price is $2.44 and resistance is $2.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TMCI shares will trade within this expected range on the day.